Vai alla homepage
4.6/5
TrustPilot

I migliori medici di Immunoterapia con Keytruda (Pembrolizumab) a Sivas - TOP-1 medici

Confronta i migliori medici di Immunoterapia con Keytruda (Pembrolizumab) e i prezzi in Turchia. Trova qui la tua scelta ideale.

Richiedi preventivi da 3 migliori specialisti di Immunoterapia con Keytruda (Pembrolizumab) in Turchia

Selezioneremo i migliori medici in base alle tue esigenze e al tuo budget.

Medici top

1

Turchia

Recensioni

14000+

Da pazienti reali

Scegli il paese con i migliori prezzi per i servizi medici

Confronta i prezzi di Immunoterapia con Keytruda (Pembrolizumab) nei principali paesi

Tocca un paese per vedere i migliori medici e i prezzi

Turkey
Ukraine
South Korea
Mexico
Czech Republic
Canada
$3,300 - $10,000
$4,500 - $8,000
$5,200 - $8,500
$7,000 - $11,000
$7,500 - $10,500
$7,800 - $11,200
$0
$2,000
$4,000
$6,000
$8,000
$10,000
$12,000

Quanto pagano davvero i pazienti Bookimed per Immunoterapia con Keytruda (Pembrolizumab) in Turchia

Gamma più richiesta

$1.5K

$3K

$4.5K

$7.5K+

$10.5K+

$1,100 – $4,200

La maggior parte dei pazienti paga in questa fascia

Il costo esatto dipende dal medico scelto, dalla tecnica, dalle aree trattate e dalle tue esigenze individuali.

Ottieni un preventivo preciso per il tuo caso.

Ricevi piani di trattamento personalizzati gratuiti e scegli l'opzione migliore. Nessun impegno · Nessun costo per i nostri servizi

Scegliere una clinica all'estero può essere stressante. Da Bookimed, con oltre 800.000 pazienti aiutati, comprendiamo le tue preoccupazioni. Sappiamo come trovare medici affidabili, le migliori opzioni per rapporto qualità-prezzo e soluzioni anche per casi complessi. Siamo qui per guidarti in ogni fase del tuo percorso sanitario.

Yan Matsiivskiy

Capo del team dei coordinatori medici

Oltre 4300+ viaggi assistiti di pazienti

3 anni su Bookimed

278 pazienti da Turkey hanno trovato il loro medico tramite noi questo mese

Come troverai il medico perfetto per te

1

Quiz da 2 minuti

Dicci il tuo obiettivo, budget e tempistiche

2

Abbinamento umano + IA

Il nostro algoritmo trova le corrispondenze, il coordinatore verifica l'idoneità

3

Le tue opzioni pronte

Confronta prezzi, pacchetti, date. Chatta con il tuo coordinatore

Tante opzioni e non sai cosa scegliere?

Il tuo personale Il coordinatore Bookimed ti aiuta a trovare il chirurgo perfetto per le tue esigenze

  • Ti supporta 24/7 in ogni fase
  • Ti aiuta a trovare il medico più adatto e gestisce tutte le comunicazioni con le cliniche
  • Coordina viaggio, alloggio e trasferimenti

Guida il tuo percorso di cura

Coordinatori personali medici qualificati

Peguy Beaugris
Tetyana Hyrych
Zekra Eldeeb
Victoria Olayinka
Iryna Sydorchuk
Tetiana Ihnatiuk

Come scegliere il medico e la clinica giusti: consigli degli esperti

Quando scegli un medico o una clinica, tieni presente questi punti chiave:
Controlla le credenziali
Verifica le certificazioni di enti come ISAPS, JCI o degli ordini medici pertinenti.
Verifica i tassi di successo
Scegli medici con grande esperienza e comprovata competenza nel trattamento specifico.
Leggi le recensioni dei pazienti
Recensioni reali dei pazienti Bookimed per conoscere la loro esperienza.
Assicura una comunicazione efficace
Scegli cliniche che offrono servizio di traduzione per facilitare il trattamento.
Chiedi informazioni sui servizi
Conferma se il prezzo include servizi come alloggio, trasferimenti locali e assistenza post-trattamento per evitare costi nascosti.

Bookimed Insights: Principali specialisti in Immunoterapia con Keytruda (Pembrolizumab) in Turchia (2026)

Bookimed ha coordinato 23 richieste per Immunoterapia con Keytruda (Pembrolizumab) in Turchia, collaborando con 1 specialisti di alto livello. I medici in questa tabella sono selezionati in base alle loro credenziali internazionali, esperienza clinica e risultati dei pazienti. La classifica del 2026 è composta da dati verificati su casi reali e dai programmi attuali delle nostre cliniche partner.
ClassificaMedicoesperienzaBuona scelta perCosa li distingueClinica e posizioneConsulto

FAQ

Queste domande frequenti provengono da pazienti reali che cercano assistenza medica tramite Bookimed. Le risposte sono fornite da coordinatori medici esperti e rappresentanti affidabili delle cliniche.

Who are the leading medical oncologists in Turkey specializing in Keytruda (pembrolizumab) immunotherapy?

Turkey serves as an international oncology hub where board-certified medical oncologists provide personalized pembrolizumab regimens. Leading specialists at JCI-accredited facilities integrate advanced biomarker testing to target specific malignancies. Doctors often hold international fellowships and ESMO certifications to deliver high-quality immunotherapy protocols.

  • Dr. Yesim Yildirim: ESMO-certified professor with immunooncology training from Mount Vernon Cancer Centre in London.
  • Dr. Bulent Karagoz: Specializes in tumor immunology and targeted therapies with 20+ years of oncology experience.
  • Dr. Mustafa Solak: Features clinical expertise from the MD Anderson Cancer Center in the United States.
  • Dr. Abdullah Sakin: Leads medical oncology at a major university hospital focusing on immunotherapy treatments.

Bookimed Expert Insight: Data shows that top Turkish oncologists like Dr. Yesim Yildirim and Dr. Bulent Karagoz have authored 40+ to 80+ scientific publications. This research focus often includes tumor biology and immunotherapy response. At Anadolu Medical Center, these specialists follow Johns Hopkins Medicine protocols for checkpoint inhibitor administration.

Patient Consensus: Patients note that major hospitals focus on honest care rather than unnecessary tests. They appreciate how doctors explain immunotherapy side effects clearly. Coordination with professional guides at facilities like Florence Nightingale makes the difficult treatment journey feel more supportive.

Which criteria do Turkish doctors use to determine if a patient is eligible for Keytruda?

Turkish oncologists determine Keytruda eligibility using advanced biomarker status and tumor pathology. Doctors prioritize PD-L1 expression levels along with MSI-H or dMMR status. They evaluate performance scores and organ health to confirm the immune system can tolerate intensive therapy. Cancer stage and prior treatment history also guide these clinical decisions.

  • Biomarker testing: Doctors verify PD-L1 expression through TPS or CPS scores for targeted response.
  • Molecular profile: Testing confirms MSI-H or dMMR status across various solid tumor types.
  • Performance status: Patients must have an ECOG score of 0 or 1 for treatment.
  • Organ function: Evaluations include renal, hepatic, and cardiovascular panels to avoid side effects.

Bookimed Expert Insight: Expert oncologists in Turkey often hold specialized certifications from the European Society for Medical Oncology (ESMO). For example, Dr. Seref Komurcu and Dr. Yesim Yildirim at Anadolu Medical Center are both ESMO-certified. This international accreditation means they follow standardized global protocols for matching immunotherapy to specific genetic tumor profiles.

Patient Consensus: Patients note that having complete pathology and molecular reports is essential before arriving in Turkey. They often feel relieved when doctors explain the results of genetic testing simply. Many were surprised that physical fitness and prior chemo history mattered as much as the cancer stage.

How do doctors in Turkey manage the specific side effects of Pembrolizumab?

Turkish oncologists manage Pembrolizumab side effects by following international protocols to identify and treat immune-related adverse events. They use a multidisciplinary approach involving specialists like endocrinologists and pulmonologists. Specialists often pause treatment and start steroid therapy to resolve complications before they escalate.

  • Multidisciplinary boards: Teams of specialists collaborate to monitor multi-organ toxicities and coordinate care.
  • Toxicity grading: Doctors use standard scales to dictate interventions like holding doses or starting steroids.
  • Baseline profiling: Clinicians perform diagnostic screenings and liver panels before starting the first infusion.
  • Hormonal management: Specialists provide long-term hormone replacement for endocrine side effects while continuing therapy.

Bookimed Expert Insight: Turkish oncology centers like Anadolu Medical Center benefit from high-level international training and academic leadership. For example, Dr. Yesim Yildirim is ESMO-certified with advanced training from Mount Vernon Cancer Center in London. This global expertise allows doctors to apply the latest clinical trials and research-based protocols when managing complex immunotherapy reactions.

Patient Consensus: Patients note that even minor fatigue or skin rashes require immediate reporting to the medical team. They emphasize that managing side effects involves regular lab tests rather than a one-time fix. Many feel safer knowing their doctors respond quickly to symptom logs and coordinate with other specialists.

What administrative and medical steps must international patients complete with Turkish doctors to begin treatment?

International patients must complete an official medical evaluation and secure state-regulated documentation to begin Keytruda treatment in Turkey. Specialized oncologists require a thorough review of pathology reports and English-translated medical history. Patients must also obtain a formal invitation letter from an accredited facility to process medical visas.

  • Medical record review: Upload diagnostic summaries and tumor biology reports for online consultation.
  • Official invitation letter: Secure a hospital-signed document detailing the planned immunotherapy schedule.
  • In-person oncology exam: Complete a physical evaluation with a Turkish board-certified oncologist.
  • Confirmation diagnostics: Run local blood tests and radiological imaging to verify dosages.

Bookimed Expert Insight: Turkish oncology centers often combine international standards with diverse specialized training. For example, Dr. Yesim Yildirim at Anadolu Medical Center trained in both Israel and at the Mount Vernon Cancer Center in London. This international exposure allows doctors to adapt Keytruda protocols for complex cases using various global methodologies.

Patient Consensus: Patients note it is simpler than expected to get treatment started once documents are ready. Many felt relieved having an English-speaking coordinator handle the paperwork at the hospital. They often mention that seeing the doctor face-to-face for the first time helped clear up any lingering questions about the therapy steps.